Semax

The Semax complex is designed to mimic the natural regulatory activity of the adrenocorticotropic hormone (ACTH) and melanocortin systems, focusing on neuroprotection and cognitive enhancement.

Semax acts as a stable, heptapeptide analog of ACTH(4-10), influencing the central nervous system without the systemic hormonal side effects of traditional corticosteroids.

By modulating the expression of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF), researchers can observe a sustained increase in neuroplasticity and neuronal survival. Semax bypasses the rapid degradation typically seen in natural peptides, allowing for a more robust observation of mRNA expression in the hippocampus and frontal cortex than original ACTH fragments could achieve alone.

Research Synergy & Pathways

• Neurotrophic Signaling: Investigating the "dual-action" up-regulation of BDNF and TrkB receptors to promote neuronal growth and synaptic density.

• Ischemic Neuroprotection: Studying the peptide's ability to mitigate glutamate excitotoxicity and inflammatory cytokines during hypoxic or stroke-model simulations.

• Cognitive Enhancement & Focus: Analyzing the modulation of the dopamine and serotonin systems to observe changes in learning retention, mental clarity, and sustained attention.

• Anticoagulant & Fibrinolytic Activity: Observing the non-nootropic effects of Semax on blood flow and microcirculation, particularly its potential to inhibit platelet aggregation in laboratory models.

SOLD FOR RESEARCH PURPOSES ONLY